ATE205824T1 - Verfahren zur herstellung von citalopram - Google Patents

Verfahren zur herstellung von citalopram

Info

Publication number
ATE205824T1
ATE205824T1 AT98905125T AT98905125T ATE205824T1 AT E205824 T1 ATE205824 T1 AT E205824T1 AT 98905125 T AT98905125 T AT 98905125T AT 98905125 T AT98905125 T AT 98905125T AT E205824 T1 ATE205824 T1 AT E205824T1
Authority
AT
Austria
Prior art keywords
citalopram
compound
halogen
formula
grignard reagent
Prior art date
Application number
AT98905125T
Other languages
English (en)
Inventor
Hans Petersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE205824T1 publication Critical patent/ATE205824T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
AT98905125T 1997-07-08 1998-03-03 Verfahren zur herstellung von citalopram ATE205824T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5278897P 1997-07-08 1997-07-08
DK82697 1997-07-08
PCT/DK1998/000081 WO1998019513A2 (en) 1997-07-08 1998-03-03 Method for the preparation of citalopram

Publications (1)

Publication Number Publication Date
ATE205824T1 true ATE205824T1 (de) 2001-10-15

Family

ID=26064729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98905125T ATE205824T1 (de) 1997-07-08 1998-03-03 Verfahren zur herstellung von citalopram

Country Status (23)

Country Link
US (1) US6229026B1 (de)
EP (1) EP1015416B1 (de)
JP (1) JP3526581B2 (de)
KR (1) KR100357975B1 (de)
CN (1) CN1206207C (de)
AT (1) ATE205824T1 (de)
AU (1) AU737610B2 (de)
BG (1) BG64823B1 (de)
CA (1) CA2291067C (de)
CZ (1) CZ291440B6 (de)
DE (2) DE69801764T2 (de)
DK (1) DK1015416T3 (de)
EA (1) EA001728B1 (de)
ES (1) ES2148120T3 (de)
HU (1) HU228744B1 (de)
IL (2) IL133511A (de)
IS (1) IS2023B (de)
NO (1) NO322146B1 (de)
NZ (1) NZ501737A (de)
PT (1) PT1015416E (de)
SK (1) SK283309B6 (de)
TR (1) TR200000066T2 (de)
WO (1) WO1998019513A2 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
PL199423B1 (pl) * 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
CN1149208C (zh) 1998-12-23 2004-05-12 H.隆德贝克有限公司 制备5-氰基2-苯并[c]呋喃酮的方法
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
NZ514671A (en) * 1999-04-14 2003-10-31 H Method for the preparation of citalopram
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991486A1 (it) * 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
EP1298124B1 (de) 1999-10-25 2007-02-28 H. Lundbeck A/S Verfahren zur Herstellung von Citalopram
CH692298A5 (de) 1999-10-25 2002-04-30 Lundbeck & Co As H Verfahren zur Herstellung von Zwischenstufen für die Citalopramsynthese sowie zur Herstellung von Escitalopram.
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
EA004742B1 (ru) 1999-12-28 2004-08-26 Х.Лундбекк А/С Способ получения циталопрама
WO2001049672A1 (en) * 1999-12-30 2001-07-12 H. Lundbeck A/S Method for the preparation of citalopram
TR200201783T2 (tr) 2000-01-14 2002-12-23 H. Lundbeck A/S 5-Siyanofatalid hazırlamak için yöntem
IT1317729B1 (it) * 2000-01-18 2003-07-15 Norpharma S P A Procedimento per la preparazione della 5-carbossiftalide.
NL1017415C1 (nl) 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB0005477D0 (en) * 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
CZ20023100A3 (cs) * 2000-03-13 2003-02-12 H. Lundbeck A/S Způsob výroby citalopramu
KR20020080481A (ko) 2000-03-13 2002-10-23 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조 방법
SK14512002A3 (sk) 2000-03-14 2003-03-04 H. Lundbeck A/S Spôsob výroby citalopramu, medziprodukt a citalopram výrobený týmto spôsobom
EP1274699A1 (de) * 2000-03-16 2003-01-15 H. Lundbeck A/S Verfahren zur herstellung von 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofuranen
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
IL144817A0 (en) * 2000-08-18 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
IT1319686B1 (it) * 2000-12-12 2003-10-23 C D Farmasint S R L Procedimento di preparazione di citalopram.
JP3798982B2 (ja) 2000-12-22 2006-07-19 ハー・ルンドベック・アクチエゼルスカベット 純粋なシタロプラムの製造方法
CA2359810C (en) 2000-12-28 2002-11-05 H. Lundbeck A/S Process for the preparation of pure citalopram
DE10112828C1 (de) * 2000-12-28 2002-11-21 Lundbeck & Co As H Verfahren zur Herstellung von Citalopram
EP1355897A1 (de) 2001-01-30 2003-10-29 Orion Corporation Fermion Verfahren zur herstellung von 1-(3-dimethylaminopropyl)-1-(4-fluorphenyl)-1,3-dihydrobenzofuran-5-carbonitrile
BG65271B1 (bg) * 2001-06-18 2007-11-30 H. Lundbeck A/S Метод за получаване на циталопрам
IN192057B (de) * 2001-07-19 2004-02-14 Ranbaxy Lab Ltd
HRP20031073A2 (en) 2001-07-31 2004-04-30 Lundbeck & Co As H Crystalline composition containing escitalopram
PT1281707E (pt) * 2001-08-02 2005-04-29 Infosint Sa Processo para a preparacao de isobenzofuranos 5-substituidos
GR1004635B (el) * 2001-08-14 2004-07-14 H@Αlundbeckαa@Sαα Μεθοδοσαπαρασκευησατησασιταλοπραμης@αα
EP1288211A1 (de) * 2001-08-28 2003-03-05 Sekhsaria Chemicals Ltd. Verbessertes Verfahren zur Herstellung von Citalopram-Hydrobromid aus 5-Bromphthalid
WO2003057132A2 (en) 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB2387844B (en) * 2002-02-27 2005-05-11 Matrix Lab Ltd Separation of impurities from a crude mixture of citalopram
HU0200980D0 (de) * 2002-03-14 2002-05-29 Gabor S Pal Dr
BG65515B1 (bg) * 2002-07-26 2008-10-31 H. Lundbeck A/S Метод за получаване на 5-цианофталид
AU2002330730A1 (en) * 2002-08-14 2004-03-03 Natco Pharma Limited Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
ITMI20030479A1 (it) * 2003-03-13 2004-09-14 Adorkem Technology S P A Procedimento per la preparazione di un ciano-isobenzofurano.
CN101362743A (zh) * 2003-03-21 2009-02-11 H.隆德贝克有限公司 用于制备西酞普兰和依他普仑的中间体
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
DE60300502T2 (de) * 2003-10-28 2006-02-23 Adorkem Technology S.P.A., Costa Volpino Verfahren zur Herstellung von Citalopram
KR101166280B1 (ko) 2004-08-23 2013-11-27 썬 파마 글로벌 에프제트이 시탈로프램 및 에난티오머의 제조 방법
TWI347942B (en) 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (de) 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
CZ291440B6 (cs) 2003-03-12
US6229026B1 (en) 2001-05-08
IS5300A (is) 1999-12-14
NZ501737A (en) 2001-10-26
IL133511A0 (en) 2001-04-30
CN1206207C (zh) 2005-06-15
NO20000008L (no) 2000-01-03
EA001728B1 (ru) 2001-08-27
NO20000008D0 (no) 2000-01-03
IL153125A (en) 2008-11-03
SK32000A3 (en) 2000-07-11
KR20010021516A (ko) 2001-03-15
ES2148120T3 (es) 2002-01-16
BG104116A (en) 2000-12-29
EA200000102A1 (ru) 2000-06-26
AU737610B2 (en) 2001-08-23
CN1495157A (zh) 2004-05-12
DK1015416T3 (da) 2001-11-05
HUP0003177A3 (en) 2002-12-28
AU6609898A (en) 1998-05-29
NO322146B1 (no) 2006-08-21
HUP0003177A2 (hu) 2001-04-28
IS2023B (is) 2005-08-15
ES2148120T1 (es) 2000-10-16
BG64823B1 (bg) 2006-05-31
PT1015416E (pt) 2002-03-28
DE1015416T1 (de) 2000-10-05
KR100357975B1 (ko) 2002-10-25
WO1998019513A2 (en) 1998-05-14
EP1015416A2 (de) 2000-07-05
HU228744B1 (en) 2013-05-28
WO1998019513A3 (en) 2000-05-04
DE69801764T2 (de) 2002-07-04
JP3526581B2 (ja) 2004-05-17
DE69801764D1 (de) 2001-10-25
IL133511A (en) 2004-05-12
CA2291067C (en) 2002-07-30
SK283309B6 (sk) 2003-05-02
CA2291067A1 (en) 1998-05-14
TR200000066T2 (tr) 2000-11-21
JP2002509526A (ja) 2002-03-26
EP1015416B1 (de) 2001-09-19
CZ200062A3 (cs) 2000-07-12

Similar Documents

Publication Publication Date Title
DE69801764D1 (de) Verfahren zur herstellung von citalopram
DE69714480D1 (de) Verfahren zur Herstellung von Citalopram
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
NO932870D0 (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
DE69803982D1 (de) Verfahren zur herstellung von 2-alkoxyestradiolen
ATE194614T1 (de) Verfahren zur herstellung von 3- arylbenzofuranonen
ATE210136T1 (de) Verfahren zur herstellung von alkylhydrogenchlorsilanen
ATE519747T1 (de) Verfahren zur herstellung von cyclopentaägüchinazolin-derivaten
DE3576952D1 (de) Verfahren zur herstellung von 4-phenyl-pyrrol-derivaten.
DE69707341D1 (de) Verfahren zur Herstellung von 4-Aryl-3-Hydroxymethyl-piperidinen
DE69106003D1 (de) Verfahren und zwischenprodukte zur herstellung von azabicyclo[2.2.2]octan-3-iminen.
DE60105441D1 (de) Verfahren zur herstellung von pantoprazol und zwischenprodukte dieses verfahrens
ATE202071T1 (de) Verfahren zur herstellung von alph-beta- ungesättigten trifluormethylcarboxylverbindungen
ES541544A0 (es) Un metodo de preparar bestatinas
DE59803194D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
DE69729631D1 (de) Verfahren zur herstellung von granisetron
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
ATE165824T1 (de) Verfahren zur herstellung von 2-perfluoroalkyl-3- oxazolin-5-one
DE59908757D1 (de) Verfahren zur herstellung von atropasäureethylester
ATE260267T1 (de) Verfahren zur herstellung von c-4-deacetyltaxanen
DE69919132D1 (de) Verfahren zur herstellung von s-alkylcysteinen
BR9810499A (pt) Método e processo para preparação de citalopram; intermediário para tal preparação e sua composição farmacêutica antidepressiva
KR850005842A (ko) 질소-함유 포화 삼중환 디온

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification